Study into conolidine has resulted in discovery of the opioid receptor in the body identified as ACKR3/CXCR7. ACKR3 seems to be the most wanted target for conolidine, which also disregards the other 4 classical opioid receptors(3). Sign in like a member to discover when there is clinical evidence demonstrating https://baruchd555yju9.bloggactif.com/profile